Published in Blood Weekly, January 13th, 2005
The findings of the project, which was led by Professor Paul Thornalley, of the Disease Mechanisms and Therapeutics Research Group in the department of biological sciences, suggest these markers could be used to assess damage to the liver and the likelihood of developing cirrhosis which could have a significant effect on choosing appropriate therapy.
Cirrhosis is scarring of the liver involving the formation of fibrous (scar) tissue. There is severe impairment of liver function in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.